Scholars Central

Conference abstractPublished 10 Aug 2015

Separation of protein from non-proteinaceous particles in biopharmaceutical formulations with MVAS by microflow imaging MFI

Authors: Zahir Akhunzada

Bristol-Myers Squibb, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The presence of sub-visible particles (SVPs) is a major challenge in the development of therapeutic protein formulations. Distinction between proteinaceous and non-proteinaceous SVPs is vital in monitoring the formulation stability. The current compendial method based on light obscuration (LO) has limitations in analyzing translucent particles, requires large analysis volume and therefore demands urgent need for an unambiguous method to characterize SVPs. A number of attempts have been made to characterize SVPs, albeit with limited success. This presentation reveals a method that successfully characterizes and distinguishes, both potentially proteinaceous and non-proteinaceous SVPs in protein formulations by using Microflow Imaging (MFI) in conjunction with the MVAS (MFI View Analysis Suite) software.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectPharmaceutical Sciences
  • SubjectPhysics & Astronomy
  • SubjectRadiology & Imaging
  • BylineArticles whose byline prints “Zahir Akhunzada”